I never said the conference wasn't worthwhile - just that 1AD shouldn't be attending. It is a pointless exercise for them to continually pedal the same pre-clinical story until they have some hard data. The story is 'known' - it just isn't being 'bought' atm. And it annoys we that they are doing so so soon after a somewhat botched capital raising.
On reflection I'll stick with naive indignation.
- Forums
- ASX - By Stock
- Ann: AdAlta to present at 2019 Bioshares Biotech Summit
I never said the conference wasn't worthwhile - just that 1AD...
Featured News
Add 1AD (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $11.25K | 433.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1312894 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 437561 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1312894 | 0.025 |
1 | 500000 | 0.024 |
1 | 29010 | 0.023 |
1 | 45450 | 0.022 |
2 | 1047615 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 437561 | 2 |
0.029 | 108304 | 2 |
0.035 | 138786 | 2 |
0.037 | 85000 | 1 |
0.045 | 306386 | 3 |
Last trade - 14.55pm 02/07/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |